Background:
Taxus is a valuable woody species with important medicinal value. The bark of Taxus can produce
taxol, a natural antineoplastic drug that is widely used in the treatment of breast, ovarian and lung cancers. However, the low
content of taxol in the bark of Taxus can not meet the growing clinical demands, so the current research is on finding ways
to increase taxol production.
Objective:
In this review, the research progress of taxol including the factors affecting the taxol content, biosynthesis pathway of taxol, production of taxol in vitro and the application of multi-omics approaches in Taxus as well as future research
prospects will be discussed.
Results and Conclusion:
The taxol content is not only dependent on the species, age and tissues, but also affected by light,
moisture levels, temperature, soil fertility and microbes. Most of the enzymes in taxol biosynthesis pathway have been identified and characterized. Total chemical synthesis, semi-synthesis, plant cell culture and biosynthesis in endophytic fungi
have been explored to product taxol. Multi-omics have been used to study on Taxus and taxol. Further efforts in the identification of unknown enzymes in taxol biosynthesis pathway, establishment of the genetic transformation system in Taxus and
the regulatory mechanism of taxol biosynthesis and Taxus cell growth will play a significant role in improving the yield of
taxol in Taxus cells and plants.